Fluoroquinolone resistance in Salmonella Typhi [5]

British Medical Journal

Volumn 333, Issue 7563, 2006, Pages 353-354

  Cooke, Fiona J ^a   Wain, John ^a   Threlfall, E John ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SALMONELLA TYPHI; TYPHOID FEVER; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; NOTE;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 33747595403     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7563.353-b     Document Type: Letter

References (5)

1. Parry CM, Karunanayake L, Coulter JB, Beeching NJ. Test for quinolone resistance in typhoid fever. BMJ 2006;333:260-1. (29 July.)
2. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006;333:78-82. (8 July.)
3. Cooke FJ, Day M, Wain J, Ward LR, Threlfall EJ. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003). Trans R Soc Trop Med Hyg (in press).
4. Anonymous. A pilot of enhanced surveillance of enteric fever in England, Wales and Northern Ireland. Commun Dis Rep CDR Wkly 2006;16(18)3-4.
5. Walker RA, Skinner JA, Ward LR, Threlfall EJ. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin. Int J Antimicrob Agents 2003;22(6):622-5.